NEUROBLASTOMA
Clinical trials for NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for kids with tough cancers
Disease control TerminatedThis study tested a combination of an immunotherapy drug (nivolumab) and low-dose chemotherapy in children and teenagers whose solid tumors had not responded to standard treatments. The goal was to see if the combination was safe and could help control the cancer. The trial was s…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New radiation therapy shows promise for tough childhood cancer
Disease control TerminatedThis study tested a new treatment called 67Cu-SARTATE in children with high-risk neuroblastoma, a serious nerve cell cancer. The treatment delivers radiation directly to tumor cells. The goal was to find the safest dose and see if it shrinks tumors. The study was stopped early, b…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Tailored cancer cocktail fails to advance in Kids' neuroblastoma trial
Disease control TerminatedThis study tested whether giving children with relapsed neuroblastoma a drug combination tailored to their tumor's genetic changes could help shrink the cancer. Participants first had a biopsy to find specific DNA errors, then received targeted drugs if a match was found. The tri…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Yael P Mosse • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Cancer drug cocktail falls short in Kids' trial
Disease control TerminatedThis early-phase study tested a combination of three drugs (ribociclib, topotecan, and temozolomide) in children and young adults with neuroblastoma or other solid tumors that had come back or not responded to treatment. The goal was to find a safe dose and see if the combination…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC